CostantineAlbanyMD(He/Him)

PubMed

• 1 citations
  Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
  Emanuel Bührer, David D'Haese, Gedske Daugaard, Ronald de Wit, Costantine Albany
  European Journal of Cancer. 2024-05-01
• Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
  Tomi Jun, Noah M Hahn, Guru Sonpavde, Constantine Albany, Gary R MacVicar
  The Oncologist. 2022-06-08
• 16 citations
  Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.
  Christopher J Sweeney, Ivor J Percent, Sunil Babu, Jennifer L Cultrera, Bryan A Mehlhaff
  Clinical Cancer Research. 2022-06-01

Journal Articles

• Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting  
  Rudolph M Navari, Costantine Albany, Charles L Loprinzi, JAMA Oncology
• Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  
  Richard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
• Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy  
  Shalaby A, El-Saed A, Voigt A, Albany C, Saba S, Pacing Clin Electrophysiol (PACE), 1/1/2008

Books/Book Chapters

• Hepatocellular Carcinoma 
  Chapter: Targeted Therapies for Hepatocellular Carcinoma. 
  Jonas W. Feilchenfeldt, Eileen M. O'Reilly, Costantine Albany and Ghassan K. Abou-Alfa2011
• Cancer Management: A Multidisciplinary Approach 
  Chapter: Testicular Cancer 
  Costantine Albany, Nasser H. Hanna, Patrick J. Loehrer, Atreya Dash, Mark K. Buyyounouski, Douglas SkareckyEdition 16th,

Abstracts/Posters

• Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors.
  Costantine Albany, Darren Feldman, Lawrence Garbo, Lawrence Einhorn, GU ASCO, 1/1/2013
• A retrospective analysis of patients with intermediate risk germ cell tumor (IRGCT) treated at Indiana university from 2000-2010.
  Costantine Albany, Shailesh R. Satpute, Mary J. Brames, Yaman Suleiman, Nawar Al Nasrallah, Susan M. Perkins, Nasser H. Hanna, Lawrence H. Einhorn, ASCO, 1/1/2012
• Overall survival (OS) prognostic factors in metastatic castrate resistant prostate cancer (mCRPC) patients retreated with docetaxel (D).
  Shilpa Rashmikant Shah, Costantine Albany, Noah M. Hahn, ASCO, 1/1/2012

Lectures

• Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy. 
  2019 ASCO Annual Meeting - 6/1/2019
• "Update on the Treatment of Prostate Cancer" 
  1/20/2013
• Grand Round: "Dissecting the molecular pathways of testicular germ cell tumor pathogenesis; from initiation to treatment resistance" 
  Indiana University Simon Cancer Center - 1/4/2013
• "Chemotherapy Induced Nausea and Vomiting (CINV)" 
  1/2/2013
• Join now to see all